Cargando…
Inhibition of an Erythrocyte Tyrosine Kinase with Imatinib Prevents Plasmodium falciparum Egress and Terminates Parasitemia
With half of the world’s population at risk for malaria infection and with drug resistance on the rise, the search for mutation-resistant therapies has intensified. We report here a therapy for Plasmodium falciparum malaria that acts by inhibiting the phosphorylation of erythrocyte membrane band 3 b...
Autores principales: | Kesely, Kristina R., Pantaleo, Antonella, Turrini, Francesco M., Olupot-Olupot, Peter, Low, Philip S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5074466/ https://www.ncbi.nlm.nih.gov/pubmed/27768734 http://dx.doi.org/10.1371/journal.pone.0164895 |
Ejemplares similares
-
Identification of tyrosine kinase inhibitors that halt Plasmodium falciparum parasitemia
por: Kesely, Kristina, et al.
Publicado: (2020) -
Increased adhesion of Plasmodium falciparum infected erythrocytes to ICAM-1 in children with acute intestinal injury
por: Church, James A., et al.
Publicado: (2016) -
Syk Kinase Inhibitors Synergize with Artemisinins by Enhancing Oxidative Stress in Plasmodium falciparum-Parasitized Erythrocytes
por: Tsamesidis, Ioannis, et al.
Publicado: (2020) -
Imatinib augments standard malaria combination therapy without added toxicity
por: Chien, Huynh Dinh, et al.
Publicado: (2021) -
Co-option of Plasmodium falciparum PP1 for egress from host erythrocytes
por: Paul, Aditya S., et al.
Publicado: (2020)